Invention Grant
- Patent Title: Methods for inhibition of HAO1 (hydroxyacid oxidase 1 (glycolate oxidase)) gene expression
-
Application No.: US16630800Application Date: 2018-07-12
-
Publication No.: US11261447B2Publication Date: 2022-03-01
- Inventor: David V. Erbe , Tracy L. McGregor
- Applicant: Alnylam Pharmaceuticals, Inc.
- Applicant Address: US MA Cambridge
- Assignee: Alnylam Pharmaceuticals, Inc.
- Current Assignee: Alnylam Pharmaceuticals, Inc.
- Current Assignee Address: US MA Cambridge
- Agency: McCarter & English, LLP
- Agent Maria Laccotripe Zacharakis; Deborah L. Nagle
- International Application: PCT/US2018/041891 WO 20180712
- International Announcement: WO2019/014491 WO 20190117
- Main IPC: C12N15/113
- IPC: C12N15/113 ; A61P13/12 ; A61K9/00 ; A61K45/06

Abstract:
The invention relates methods of using RNAi agents to inhibit expression of HAO1 and methods of treating subjects having, e.g., PH1.
Public/Granted literature
- US20200165616A1 Methods For Inhibition Of HAO1 (Hydroxyacid Oxidase 1 (Glycolate Oxidase)) Gene Expression Public/Granted day:2020-05-28
Information query
IPC分类: